Granisetron
Sold as Kytril, Xixia granisetron, Mylan-granisetron, Granitril, Granicip, Cipla granisetron, Adco granisetron, Sandoz granisetron ivi, Grantryl, Grantyl, Aspen granisetron, Granisetron ( ) fresenius, Granisetron teva
1-Methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
Drag to rotate. Structure from PubChem CID 5284566.
Background
Registration
- Applicants
- 12
- Registrations
- 28
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmaco Distribution (Pty) Ltd1 of 4 cancelled | Kytril | 1 mg, 1 mg/1 ml, 2 mg, 3 mg/3 ml | 280162, 300346, 310082, Y0272 | S4 | None |
| Viatris South Africa (Pty) Ltd | Xixia granisetron | injection | 290545 | S4 | None |
| Viatris Healthcare (Pty) LtdCancelled | Mylan-granisetron | 3 mg/3 ml | 410048 | S4 | None |
| Unimed Healthcare (Pty) Ltd | Granitril | injection, 1 mg | 410295, 410364 | S4 | None |
| Cipla Medpro (Pty) Ltd2 of 4 cancelled | Granicip, Cipla granisetron | 1 mg, 2 mg | 410397, 410398, 410399, 410400 | S4 | None |
| Adcock Ingram Critical Care (Pty) Ltd | Adco granisetron | 1 mg/1 ml, 3 mg/3 ml | 411079, 411080 | S4 | None |
| Sandoz South Africa (Pty) LtdCancelled | Sandoz granisetron ivi | 1 mg/1 ml, 3 mg/3 ml | 420010, 420012 | S4 | None |
| Acino Pharma (Pty) Ltd | Grantryl | 1 mg, 1 mg/1 ml, 2 mg, 3 mg/3 ml | 421007, 421008, 440892, 440893 | S4 | None |
| Ascendis Pharma (Pty) LtdCancelled | Grantyl | 1 mg/1 ml, 3 mg/3 ml | 430527, 430528 | S4 | None |
| Pharmacare limited û woodmead | Aspen granisetron | 1 mg/1 ml, 3 mg/3 ml | 440395, 440396 | S4 | None |
| Fresenius Kabi South Africa (Pty) Ltd | Granisetron ( ) fresenius | 1 mg/ml 1 ml, 1 mg/ml 3 ml | 440671, 440672 | S4 | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Granisetron teva | 1, 3 | 450067, 450068 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Kytril 1 MG oral EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE 1 mg GRANISETRON | 1 mgOral | 28016228/5.7.2/0162 | Registered | S4 | None |
| Xixia granisetron injection EACH 3 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO 3,0 mg GRANISETRON | Injection | 29054529/5.7.2/0545 | Registered | S4 | None |
| Kytril 2 MG oral EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 2,0 mg | 2 mgOral | 30034630/5.7.2/0346 | Cancelled | S4 | None |
| Kytril 1 mg/1 ML EACH 1 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO 1,0 mg GRANISETRON | 1 mg/1 ml | 31008231/5.7.2/0082 | Registered | S4 | None |
| Mylan-granisetron 3 mg/3 ML EACH 3,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 41004841/5.7.2/0048 | Cancelled | S4 | None |
| Granitril injection EACH 1,0 ml SOLUTION CONTAINS: GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | Injection | 41029541/5.7.2/0295 | Registered | S4 | None |
| Granitril 1 MG tablets EACH TABLET CONTAINS: GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mgTablets | 41036441/5.7.2/0364 | Registered | S4 | None |
| Granicip 1 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE 1,0 mg | 1 mg | 41039741/5.7.2/0397 | Registered | S4 | None |
| Granicip 2 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE 2,0 mg | 2 mg | 41039841/5.7.2/0398 | Registered | S4 | None |
| Cipla granisetron 1 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE 1,0 mg | 1 mg | 41039941/5.7.2/0399 | Cancelled | S4 | None |
| Cipla granisetron 2 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE 2,0 mg | 2 mg | 41040041/5.7.2/0400 | Cancelled | S4 | None |
| Adco granisetron 1 mg/1 ML EACH 1,0 ml SOLUTION CONTAINS :GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/1 ml | 41107941/5.7.2/1079 | Registered | S4 | None |
| Adco granisetron 3 mg/3 ML EACH 3,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 41108041/5.7.2/1080 | Registered | S4 | None |
| Sandoz granisetron 1 mg/1 ML ivi EACH 1,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/1 ml | 42001042/5.7.2/0010 | Cancelled | S4 | None |
| Sandoz granisetron 3 mg/3 ML ivi EACH 3,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 42001242/5.7.2/0012 | Cancelled | S4 | None |
| Grantryl 1 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg | 42100742/5.7.2/1007 | Registered | S4 | None |
| Grantryl 2 MG EACH TABLET CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 2,0 mg | 2 mg | 42100842/5.7.2/1008 | Registered | S4 | None |
| Grantyl 1 mg/1 ML EACH 1,0 ml SOLUTION CONTAINS: GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/1 ml | 43052743/5.7.2/0527 | Cancelled | S4 | None |
| Grantyl 3 mg/3 ML EACH 3,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 43052843/5.7.2/0528 | Cancelled | S4 | None |
| Aspen granisetron 1 mg/1 ML EACH 1,0 ml AMPOULE CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/1 ml | 44039544/5.7.2/0395 | Registered | S4 | None |
| Aspen granisetron 3 mg/3 ML EACH 3,0 ml AMPOULE CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 44039644/5.7.2/0396 | Registered | S4 | None |
| Granisetron 1 mg/ml (1 ml) fresenius EACH 1,0 ml CONCENTRATE CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/ml 1 ml | 44067144/5.7.2/0671 | Registered | S4 | None |
| Granisetron 1 mg/ml (3 ml) fresenius EACH 3,0 ml CONCENTRATE CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 1 mg/ml 3 ml | 44067244/5.7.2/0672 | Registered | S4 | None |
| Grantryl 1 mg/1 ML EACH 1,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 mg/1 ml | 44089244/5.7.2/0892 | Registered | S4 | None |
| Grantryl 3 mg/3 ML EACH 3,0 ml SOLUTION CONTAINS :GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 mg/3 ml | 44089344/5.7.2/0893 | Registered | S4 | None |
| Granisetron teva 1 EACH 1,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 1,0 mg | 1 | 45006745/5.7.2/0067 | Cancelled | S4 | None |
| Granisetron teva 3 EACH 3,0 ml SOLUTION CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO GRANISETRON 3,0 mg | 3 | 45006845/5.7.2/0068 | Cancelled | S4 | None |
| Kytril 3 mg/3 ML EACH 3,0 ml AMPOULE CONTAINS GRANISETRON HYDROCHLORIDE EQUIVALENT TO 3,0 mg GRANISETRON | 3 mg/3 ml | Y0272Y/5.7.2/272 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Granisetron hydrochloride
S4: Granisetron
Consolidated Schedules 06 July 2026, line 6544
Pharmacological class: Anti-emetics and antivertigo preparations. (class 5.7.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.